• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算日本普通人群中明确的慢性肾脏病的患病率。

Estimating the prevalence of definitive chronic kidney disease in the Japanese general population.

机构信息

Department of Nephrology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Ten-oudai, Tsukuba, Ibaraki, 305-8575, Japan.

Division of Nephrology and Hypertension, Department of Internal Medicine, Iwate Medical University School of Medicine, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Iwate, 028-3694, Japan.

出版信息

Clin Exp Nephrol. 2021 Aug;25(8):885-892. doi: 10.1007/s10157-021-02049-0. Epub 2021 Apr 10.

DOI:10.1007/s10157-021-02049-0
PMID:33839966
Abstract

BACKGROUND

Most data on chronic kidney disease (CKD) prevalence has been based on single measurements of renal function and proteinuria. The aim was to determine the prevalence of CKD diagnosed by chronic proteinuria and/or reduced eGFR in a recent year in Japan.

METHODS

In the main study, using a population-based cohort in Japan, the overall prevalence of CKD, defined as persistent positive proteinuria and/or eGFR < 60 ml/min/1.73 m, was determined. Of 2,849,557 persons, 763,104 had data for eGFR and proteinuria in both 2014 and 2015. For estimating number of CKD cases in Japanese adults, a regional cohort data with age ranging 22-87 years (N = 22,037) was further applied to the analysis.

RESULTS

Definitive CKD was present in 2.3-23.0% of men and 1.7-17.1% of women age from 40 to 74 years in the main cohort. The estimated prevalence of reduced eGFR and/or proteinuria in the baseline year alone was 15.7% in men and 13.6% in women; the prevalence of definitive CKD was 10.9% in men and 9.2% in women. The number of CKD cases based on a single-year test in Japanese adults over 20 years of age increased from 13.3 million to 14.8 million between 2005 and 2015.

CONCLUSIONS

Recent changes in prevalence of CKD seem to be mainly caused by an increase in Japan's elderly population. Although past reports may lead to overdiagnosis of CKD by a single-year test, the estimated number of definitive CKD was 10.2 million in 2015.

摘要

背景

大多数关于慢性肾脏病(CKD)患病率的数据都是基于肾功能和蛋白尿的单次测量。本研究旨在确定在最近一年中,通过慢性蛋白尿和/或估算肾小球滤过率(eGFR)降低诊断为 CKD 的患病率。

方法

在主要研究中,我们使用日本的一项基于人群的队列研究,确定了 CKD 的总体患病率,其定义为持续性蛋白尿阳性和/或 eGFR<60ml/min/1.73m。在 2849557 人中,有 763104 人在 2014 年和 2015 年均有 eGFR 和蛋白尿数据。为了估算日本成年人 CKD 病例数,进一步将年龄在 22-87 岁的区域队列数据(n=22037)应用于分析。

结果

在主要队列中,40-74 岁男性和女性的 CKD 确诊率为 2.3%-23.0%,估计率为 15.7%和 13.6%;男性和女性的 eGFR 降低和/或蛋白尿的患病率为 10.9%和 9.2%。2005 年至 2015 年间,日本 20 岁以上成年人基于单次年度检测的 CKD 病例数从 1330 万增加到 1480 万。

结论

最近 CKD 患病率的变化似乎主要是由于日本老年人口的增加所致。虽然过去的报告可能导致单次年度检测的 CKD 过度诊断,但 2015 年估计的确诊 CKD 病例数为 1020 万。

相似文献

1
Estimating the prevalence of definitive chronic kidney disease in the Japanese general population.估算日本普通人群中明确的慢性肾脏病的患病率。
Clin Exp Nephrol. 2021 Aug;25(8):885-892. doi: 10.1007/s10157-021-02049-0. Epub 2021 Apr 10.
2
Undiagnosed and untreated chronic kidney disease and its impact on renal outcomes in the Japanese middle-aged general population.日本中年人群中未诊断和未经治疗的慢性肾脏病及其对肾脏结局的影响。
J Epidemiol Community Health. 2019 Dec;73(12):1122-1127. doi: 10.1136/jech-2019-212858. Epub 2019 Sep 28.
3
Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects.基线肾小球滤过率降低作为新发慢性肾脏病风险因素的首要地位:一项针对日本受试者的纵向研究
Nephrology (Carlton). 2017 Sep;22(9):684-689. doi: 10.1111/nep.12836.
4
Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.非白蛋白尿性慢性肾脏病向终末期肾病进展的风险:CRIC(慢性肾功能不全队列)研究。
Am J Kidney Dis. 2018 Nov;72(5):653-661. doi: 10.1053/j.ajkd.2018.02.364. Epub 2018 May 18.
5
Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.普通人群中尿白蛋白与肌酐比值和尿蛋白试纸检测在慢性肾脏病患病率及预测风险能力方面的比较(岩手县慢性肾脏病队列研究):一项基于社区的前瞻性队列研究
BMC Nephrol. 2016 May 12;17(1):46. doi: 10.1186/s12882-016-0261-3.
6
Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.摩洛哥成年人中的慢性肾脏病、高血压、糖尿病和肥胖症:如何避免过度诊断和漏诊慢性肾脏病。
Kidney Int. 2016 Jun;89(6):1363-71. doi: 10.1016/j.kint.2016.02.019. Epub 2016 Apr 13.
7
Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population.在日本普通人群中,将不检测血清肌酐仅用尿试纸作为筛查工具会低估慢性肾脏病。
Clin Exp Nephrol. 2015 Jun;19(3):474-80. doi: 10.1007/s10157-014-1019-5. Epub 2014 Aug 24.
8
Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient.采用日本系数修正的MDRD方程预测日本普通人群慢性肾脏病(CKD)的患病率。
Clin Exp Nephrol. 2007 Jun;11(2):156-163. doi: 10.1007/s10157-007-0463-x. Epub 2007 Jun 28.
9
Why overestimate or underestimate chronic kidney disease when correct estimation is possible?在有可能进行正确估算的情况下,为什么要高估或低估慢性肾脏病呢?
Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii136-ii141. doi: 10.1093/ndt/gfw267.
10
The role of cigarette smoking on new-onset of chronic kidney disease in a Japanese population without prior chronic kidney disease: Iki epidemiological study of atherosclerosis and chronic kidney disease (ISSA-CKD).在没有先前慢性肾脏病的日本人群中,吸烟对新发慢性肾脏病的作用:动脉粥样硬化和慢性肾脏病的以社区为基础的前瞻性队列研究(ISSA-CKD)。
Clin Exp Nephrol. 2020 Oct;24(10):919-926. doi: 10.1007/s10157-020-01914-8. Epub 2020 Jun 23.

引用本文的文献

1
Regression equation for kidney function based on the ultrasonographic volumetry of the renal cortex.基于肾皮质超声容积测量法的肾功能回归方程。
J Nephrol. 2025 Sep 8. doi: 10.1007/s40620-025-02417-z.
2
Dysphagia and the prevalence of chronic kidney disease: a cross-sectional study.吞咽困难与慢性肾脏病患病率:一项横断面研究
Int Urol Nephrol. 2025 Sep 1. doi: 10.1007/s11255-025-04764-z.
3
Impact of Early Rehabilitation on Functional Recovery After Kidney Transplantation: A Retrospective Cohort Study.早期康复对肾移植后功能恢复的影响:一项回顾性队列研究。

本文引用的文献

1
An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits.慢性肾脏病的年龄校准定义:原理与益处
Clin Biochem Rev. 2016 Feb;37(1):17-26.
Cureus. 2025 Aug 26;17(8):e91046. doi: 10.7759/cureus.91046. eCollection 2025 Aug.
4
Systemic inflammation is associated with reduced functional recovery in older inpatients with chronic kidney disease.全身炎症与老年慢性肾脏病住院患者功能恢复降低有关。
Int Urol Nephrol. 2025 Aug 21. doi: 10.1007/s11255-025-04721-w.
5
Function of Yogurt Fermented with the 11/19-B1 Strain in Improving the Lipid Profile and Intestinal Microbiome in Hemodialysis Patients.11/19-B1菌株发酵酸奶对改善血液透析患者血脂状况和肠道微生物群的作用
Nutrients. 2025 Jun 4;17(11):1931. doi: 10.3390/nu17111931.
6
First-time diagnosis and referral practices for individuals with CKD by primary care physicians: a study of electronic medical records across multiple clinics in Japan.初级保健医生对慢性肾脏病患者的首次诊断及转诊实践:一项针对日本多家诊所电子病历的研究
Clin Exp Nephrol. 2025 May 16. doi: 10.1007/s10157-025-02695-8.
7
Absence of progression risk of chronic kidney disease in patients with urine protein-creatinine ratio below 500 mg/g: a cohort study with competing risk analysis.尿蛋白肌酐比值低于500mg/g的慢性肾脏病患者无疾病进展风险:一项采用竞争风险分析的队列研究
Front Med (Lausanne). 2025 Mar 28;12:1502597. doi: 10.3389/fmed.2025.1502597. eCollection 2025.
8
A clinical decision support system promotes the appropriate use of drugs in hospitalized patients with kidney impairment.临床决策支持系统促进了肾功能损害住院患者合理用药。
J Pharm Health Care Sci. 2025 Apr 3;11(1):26. doi: 10.1186/s40780-025-00431-8.
9
Comparative assessment of the effects of dotinurad and febuxostat on the renal function in chronic kidney disease patients with hyperuricemia.度洛昔胺与非布索坦对慢性肾脏病高尿酸血症患者肾功能影响的比较评估
Sci Rep. 2025 Mar 15;15(1):8990. doi: 10.1038/s41598-025-94020-2.
10
Emerging New Era of Artificial Intelligence and Digital Medicine-directed Management of Chronic Kidney Disease.人工智能与数字医学导向的慢性肾脏病管理的崭新时代
JMA J. 2025 Jan 15;8(1):57-59. doi: 10.31662/jmaj.2024-0221. Epub 2024 Sep 20.